J Korean Med Assoc.  2003 Jul;46(7):605-611.

Diagnosis and Treatment of Inflammatory Bowel Disease

Affiliations
  • 1Department of General Surgery, Kyung Hee University of College of Medicine & Hospital, Korea. hjkim@khmc.or.kr

Abstract

Inflammatory bowel disease (IBD) comprises a group of idiopathic diseases of the intestine characterized by chronic inflammation of the bowel with periods of exacerbation and remission. The two major categories of IBD are ulcerative colitis and Crohn's disease, and each disease is distinct both clinically and histologically. The exact cause of IBD remains unknown, but several theories have been proposed. Primary care physicians are frequently confronted with the initial diagnosis and management of patients with IBD, and medical treatment options have rapidly expanded in recent years. This article reviews clinical presentations that are essential to establish a diagnosis in this complex disease and the treatment options available.

Keyword

Inflammatory bowel disease; Ulcerative colitis; Crohns disease; Diagnosis; Treatment

MeSH Terms

Colitis, Ulcerative
Crohn Disease
Diagnosis*
Humans
Inflammation
Inflammatory Bowel Diseases*
Intestines
Physicians, Primary Care

Reference

1. Podolsky DK. Inflammatory bowel disease. N Engl J Med. 2002. 347:417–429.
Article
6. Peeters M, Joossens S, Vermeire S, Vlietinck R, Bossuyt X, Rutgeerts P. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease. Am J Gastroenterol. 2001. 96:730–734.
Article
7. Chutkan RK, Scherl E, Waye JD. Colonoscopy in inflammatory bowel disease. Gastrointest Endosc Clin N Am. 2002. 12:463–483.
Article
9. Cohen R, Woseth DM, Thisted RA, Hanauer SB. A Meta-analysis and overview of the literature on treatment options for left-sided ulcerative colitis and ulcerative proctitis. Am J Gastroenterol. 2000. 95:1263–1276.
Article
10. Sandborn WJ. Rational selection of oral 5-aminosalicylate formulations and prodrugs for the treatment of ulcerative colitis. Am J Gastroenterol. 2002. 97:2939–2941.
Article
12. Faubion WA Jr, Loftus EV Jr, Harmsen WS, Zinsmeister AR, Sandborn WJ. The natural history of corticosteroid therapy for inflammatory bowel disease : a population-based study. Gastroenterology. 2001. 121:255–260.
Article
13. Danielsson A, Lofberg R, Persson T. A steroid enema, budesonide, lacking systemic effects for the treatment of distal ulcerative colitis or proctitis. Scand J Gastroenterol. 1992. 27:9–12.
Article
14. Greenberg GR, Feagan BG, Martin F, Sutherland LR, Thomson AB, Persson T, et al. Canadian Inflammatory Bowel Disease Study Group. Oral budesonide as maintenance treatment for Crohn's disease : a placebo-controlled, dose-ranging study. Gastroenterology. 1996. 110:45–51.
Article
17. Fraser AG, Orchard TR, Jewel DP. The efficacy of azathioprine for the treatment of inflammatory bowel disease. Gut. 2002. 50:485–489.
Article
18. Present DH, Melzer SJ, Krumholz MP, Wolke A, Korelitz BI. 6-Mercaptopurine in the management of inflammatory bowel disease : short and long-term toxicity. Ann Intern Med. 1989. 111:641–649.
Article
19. Seidman EG. 6-Mercaptopurine in maintaining remission in Crohns disease : An old friend becomes a new hero. Gastroenterology. 2000. 119:1158–1160.
Article
21. van Dullemen HM, van Deventer SJ, Hommes DW, Bijl HA, Jansen J, Woody J, et al. Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2). Gastroenterology. 1995. 109:129–135.
Article
22. Targan SR, Hanauer SB, van Deventer SJ, Mayer L, Present DH, Rutgeerts PJ, et al. Crohn's Disease cA2 Study Group. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. N Engl J Med. 1997. 337:1029–1023.
Article
23. Present DH, Rutgeerts P, Targan S, Hanauer SB, Mayer L, van Deventer SJ, et al. Infliximab for the treatment of fistulas in patients with Crohn's disease. N Engl J Med. 1999. 340:1398–1405.
Article
24. Sutherland L, Singleton J, Sessions J, Hanauer S, Krawitt E, Kelly M, et al. Double blind, placebo controlled trial of metronidazole in Crohn's disease. Gut. 1991. 32:1071–1075.
Article
25. Turunen UM, Farkkila MA, Hakala K, Seppala K, Sivonen A, Miettinen TA. Long-term treatment of ulcerative colitis with ciprofloxacin : a prospective, double-blind, placebo-controlled study. Gastroenterology. 1998. 115:1072–1078.
Article
26. Gionchetti P, Rizzello F, Venturi A, Brigidi P, Matteuzzi D, Campieri M. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis : a double-blind, placebo-controlled trial. Gastroenterology. 2000. 119:305–309.
Article
Full Text Links
  • JKMA
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr